Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients
Public ClinicalTrials.gov record NCT07116746. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Open-label, Efficacy and Safety Study of AR882 and XOI Co-administration in Participants With Uncontrolled Gout Who Have Previously Failed Uricase Treatment
Study identification
- NCT ID
- NCT07116746
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Arthrosi Therapeutics
- Industry
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Interventions
- AR882 75 mg Drug
- XOI High Dose Drug
- XOI Low Dose Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2, 2025
- Primary completion
- Oct 31, 2026
- Completion
- Jan 31, 2027
- Last update posted
- May 14, 2026
2025 – 2027
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arthrosi Investigative Site (105) | Margate | Florida | 33063 | — |
| Arthrosi Investigative Site (102) | Miami | Florida | 33155 | — |
| Arthrosi Investigative Site (109) | Tampa | Florida | 33609 | — |
| Arthrosi Investigative Site (106) | Jackson | Mississippi | 39202 | — |
| Arthrosi Investigative Site (108) | Charlotte | North Carolina | 28202 | — |
| Arthrosi Investigative Site (103) | Duncansville | Pennsylvania | 16635 | — |
| Arthrosi Investigative Site (104) | West Lake Hills | Texas | 78746 | — |
| Arthrosi Investigative Site (107) | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07116746, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 14, 2026 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07116746 live on ClinicalTrials.gov.